Navegando por Assunto "Citometria de fluxo"

Agora exibindo 1 - 4 de 4

Acesso aberto (Open Access)
Atividade antineoplásica da 1-desoxinojimiricina em modelos de câncer in vitro
(Universidade Federal do Pará, 2021-12) FONSECA, Suzanne Suely Santos da; PEREIRA JÚNIOR, Antônio; http://lattes.cnpq.br/1402289786010170; https://orcid.org/0000-0002-0808-1058
Cancer is one of the diseases that kill the most in Brazil, with alarming projections until 2030. In view of the problems related to cancer treatment, such as the compromise of healthy cells and, consequently, the presence of adverse effects, it is imperative to seek of alternative substances that may have antineoplastic effects and that are effective in the treatment of patients with this disease. In this way, the use of bioactive compounds has been widely used in the fight against neoplasms. Thus, the substance 1-deoxynojimyricin (1-DNJ) isolated from Bagassa guianensis may have great anticancer potential. In view of the problems related to cancer treatment, such as the impairment of healthy cells and, consequently adverse effects, it is necessary to search alternative substances that may have antineoplastic effects and they are effective in the treatment of patients with this disease. The objective of this study was to evaluate the effect of 1-deoxynojirimycin (1-DNJ) extracted from wood residue of the species Bagassa guianensis in different cancer cell lines to investigate possible antineoplastic actions in vitro using gastric adenocarcinoma and glioblastoma cancer cell lines. To do that, it was evaluated the effect of the substance 1-deoxynojirimycin on cell viability in vitro after 72h of treatment in cell lines ACP02 and A172. We also evaluated the effect of this bioactive compound on cell migration pattern, cell death by apoptosis and cell cycle changes using flow cytometry and reactive oxygen production. The results showed that 1-deoxynojirimycin makes a significant reduction in cell viability of cancer cell cultures in both glioblastoma (A172) and gastric cancer cell (ACP02) cell lines. The reduction in viability appears to be more effective in glioblastoma cell lines, with a common ic50 much lower when compared to other cell lines. We propose that the reduction in viability may be related to the decrease in reactive oxygen production in both lines after treatment with 1-DNJ. Besides that, 1-DNJ interrupts the cell cycle, prevents cell migration and induces necrosis-like cell death in the ACP02 lineage and apoptosis in the A172 lineage. Therefore, we suggest that 1-deoxynojirimycin may be an important and effective chemopreventive substance for the treatment of glioblastoma and gastric adenocarcinoma cancers.
Acesso aberto (Open Access)
Diagnóstico de imunofenótipos de síndromes linfoproliferativas crônicas por citometria de fluxo na Fundação HEMOPA
(2011-12) BRITO JUNIOR, Lacy Cardoso de; FEIO, Danielle Cristinne Azevedo; BARBOSA, Suane Reis; BENTES, Alessandra Quinto; FRANCÊS, Larissa Tatiane Martins
INTRODUCTION: Lymphoproliferative syndromes comprise a heterogeneous group of malignant neoplasias with different clinical behaviors, pathological factors and epidemiological characteristics, whose diagnosis may be based on lymphoid cell morphology observed in peripheral blood. OBJECTIVE: To test the diagnostic feasibility of immunophenotyping by flow cytometry for lymphoproliferative syndromes through the definition of minimal antibody panel. MATERIAL AND METHODS: During the period of July 2008 to July 2010, 47 patients from HEMOPA blood center participated in this study for differential diagnosis of lymphoproliferative syndromes subtypes by flow cytometry. RESULTS: The mean age was 68 years old. There was no statistical difference between genders, and the most frequent subtype of lymphoproliferative syndromes was chronic lymphoid leukemia/small B-cell lymphocytic lymphoma. CONCLUSION: Based on the antibody panel recommended in this investigation, the immunophenotyping method by flow cytometry associated with morphological characterization of peripheral blood samples is a reliable, rapid, feasible, and non-invasive procedure for the diagnosis of chronic lymphoproliferative syndromes.
Acesso aberto (Open Access)
Frequency of paroxysmal nocturnal hemoglobinuria in patients attended in Belém, Pará, Brazil
(2011-02) BRITO JUNIOR, Lacy Cardoso de; CARDOSO, Maria do Socorro de Oliveira; ROCHA, Euzamar Gaby; ANIJAR, Herika; CUNHA, Mariana; SARAIVA, João Carlos Pina
Paroxysmal nocturnal hemoglobinuria is a hematological disease with complex physiopathology. It is genetically characterized by a somatic mutation in the PIG-A gene (phosphatidylinositol glycan anchor biosynthesis, class A), in which the best known antigens are DAF (decay accelerating factor or CD55) and MIRL (membrane inhibitor of reactive lysis or CD59). OBJECTIVE: To determine the frequency of paroxysmal nocturnal hemoglobinuria in patients attended at the HEMOPA foundation from November 2008 to July 2009. METHOD: Thirty patients, with ages ranging from two to 79 years old and suspected of having paroxysmal nocturnal hemoglobinuria were examined. All patients were immunophenotyped by flow cytometry for the CD5, CD59, CD16 and CD45 antigens. RESULTS: Paroxysmal nocturnal hemoglobinuria was identified in nine of the thirty patients investigated. Another 3 cases had inconclusive results with CD59-negative labeling only for neutrophils. The highest frequency of paroxysmal nocturnal hemoglobinuria patients (7/9) and inconclusive cases (2/3) were between 19 years old and 48 years old, with a median of 28 years. CONCLUSION: These results show the importance of flow cytometry to identify cases in which patients are deficient in only one antigen (CD59).
Acesso aberto (Open Access)
Relato de caso de leucemia de células pilosas
(2011-12) BRITO JUNIOR, Lacy Cardoso de; BARBOSA, Suane Reis; FRANCÊS, Larissa Tatiane Martins
Hairy cell leukemia (HCL) is a rare type of B-cell non-Hodgkin's lymphoma. The clinical symptoms include splenomegaly, pancytopenia, and lymphocytosis. Studies on its carcinogenesis reveal association with exposure to agricultural chemical agents. The objective of this study was to report the case of a male patient, tractor operator, diagnosed with HCL, pancytopenia, cutaneous lesions, without splenomegaly and positive markers for B-cell lymphocytes (CD19, CD20, CD22, CD79b, CD23, Lambda, immunoglobulin M [IgM], CD25 and CD103). Although HCL is a rare disease, late diagnosis may ultimately lead to severe complications and patient's death.